Ketotifen Unit Dose Stulln

Ketotifen, the active ingredient in Ketotifen Unit Dose Stulln, is an antihistamine and mast cell stabilizer presented as a unit‑dose ophthalmic preparation for ocular use. It is employed to relieve allergic eye symptoms such as itching, redness and tearing in patients with seasonal or perennial ocular allergies.

GNH USA supplies Ketotifen Unit Dose Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Ketotifen is used to manage allergic eye conditions by stabilizing mast cells and blocking histamine receptors. - Allergic conjunctivitis: reduces itching, redness and swelling of the conjunctiva. - Seasonal allergic eye disease: alleviates symptoms triggered by pollen or other seasonal allergens. - Ocular itching and redness due to allergy: provides rapid relief of discomfort and visual irritation. - Contact lens‑related allergic irritation: helps control inflammation in users with hypersensitivity.

Ketotifen may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Blurred vision: temporary decrease in visual clarity. - Redness: mild conjunctival hyperemia. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Severe allergic reaction: signs of angioedema or anaphylaxis. - Persistent ocular pain: may indicate corneal involvement. - Vision loss: rare but requires immediate medical attention.

When using Ketotifen Unit Dose Stulln, consider the following precautions to ensure safe and effective therapy. - Avoid use in patients with known hypersensitivity to ketotifen or other antihistamines: discontinue if reaction occurs. - Caution in individuals with narrow-angle glaucoma: monitor intra‑ocular pressure. - Use with care in patients taking other ocular antihistamines or mast‑cell stabilizers: assess additive effects. - Pregnant or breastfeeding women: consult healthcare professional as safety data are limited. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Ketotifen can interact with certain medications and substances; awareness of these interactions helps prevent reduced efficacy or increased adverse effects.

Major Interactions (Avoid): - Systemic antihistamines: concurrent use may increase risk of sedation and ocular irritation. - MAO inhibitors: may potentiate antihistaminic effects leading to excessive anticholinergic activity.

Moderate Interactions (Monitor Closely): - Other ocular decongestants or anti‑inflammatory drops: may cause additive irritation. - Beta‑blocker eye drops: monitor intra‑ocular pressure changes. - CYP450 substrates: ketotifen may inhibit metabolism of drugs processed by CYP3A4, requiring dose adjustment.